Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects

NCT04108104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Cyproheptadine
DRUG: Alpress LP

Sponsor

Kinnov Therapeutics

Collaborators

[object Object]